ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Samsung jumps into novel drug R&D through Takeda deal
fiercebiotech
August 22, 2017Samsung Bioepis has begun its long-anticipated move into novel drug R&D. The offshoot of South Korean conglomerate Samsung is taking its first steps beyond the lower risk, lower reward world of biosimilars by teaming up with Takeda to co-develop drugs aga
Pharma Sources Insight July 2025
